Author:
Olney Harold J.,Le Beau Michelle M.
Publisher
Springer Berlin Heidelberg
Reference158 articles.
1. Abe A, Emi N, Tanimoto M, Terasaki H, Marunouchi T, Saito H (1997) Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood 90:4271–4277
2. Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C., Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG (2001) Common themes in the pathogenesis of acute myeloid leukemia. Oncogene 20:5680–5694
3. Allampallam K, Shetty V, Mundle S, Dutt D, Kravitz G, Reddy PL, Alvi S, Galili N, Saberwal GS, Anthwal S, Shaikh MW, York A, Raza A (2002) Biological significance of proliferation, apoptosis, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome. International Journal of Hematology 75:289–297
4. Apperley JF, Gardembas M, Melo JV, Russell-Jones R, Bain BJ, Baxter EJ, Chase A, Chessells JM, Colombat M, Dearden CE, Dimitrijevic S, Mahon FX, Marin D, Nikolova Z, Olavarria E, Silberman S, Schultheis C, Cross NC, Goldman JM (2002) Response to imatinib mesylate in patients with chronic myeloproliferative disease with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 347:481–487
5. Arland M, Fiedler W, Samalecos A, Hossfeld DK (1994) Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML). Leukemia 8:498–501